Quetiapine is an antipsychotic drug whose effect appears to be mediated through antagonist activity at the dopamine and serotonin receptors. While Quetiapine is not currently classified as a controlled substance, there have been a growing number of reports of the drug being abused both in American prisons and in general community settings. These accounts have included reports of both intranasal and intravenous uses. In this paper we report two cases of prisoners deliberately feigning psychotic symptoms for the purposes of obtaining quetiapine. In both cases there appears to be some evidence of psychological dependence and of a discontinuation syndrome when the medication was ceased. Our report adds support to the possibility that quetiapine...
Inducing manic or hypomanic symptoms is a well-documented risk during anti- depressive treatment wit...
WOS: 000255873200008PubMed: 18224291Nowadays, there is a widespread use of atypical (second-generati...
Inducing manic or hypomanic symptoms is a well-documented risk during anti- depressive treatment wit...
Quetiapine is an antipsychotic drug whose effect appears to be mediated through antagonist activity ...
Quetiapine is a new-generation antipsychotic medication approved in the treatment of schizophrenia, ...
Recent case reports in medical literatures suggest that more and more second-generation atypical ant...
This paper presents a preliminary examination of the use of quetiapine (an antipsychotic drug) among...
Background: Quetiapine, an atypical antipsychotic endowed with weak dopamine antagonist, potent 5-HT...
ABSTRACT Introduction: Case reports and poison center data have demonstrated that the second-ge...
Background: Quetiapine, an atypical antipsychotic endowed with weak dopamine antagonist, potent 5-HT...
Background: Quetiapine, an atypical antipsychotic endowed with weak dopamine antagonist, potent 5-HT...
Background: Quetiapine, an atypical antipsychotic endowed with weak dopamine antagonist, potent 5-HT...
Recent case reports in medical literatures suggest that more and more second-generation atypical ant...
Quetiapine is one of the atypical antipsychotics that were approved to be used in the treatment of s...
This document is the Accepted Manuscript version. Under embargo until 28 February 2019. Reprinted fr...
Inducing manic or hypomanic symptoms is a well-documented risk during anti- depressive treatment wit...
WOS: 000255873200008PubMed: 18224291Nowadays, there is a widespread use of atypical (second-generati...
Inducing manic or hypomanic symptoms is a well-documented risk during anti- depressive treatment wit...
Quetiapine is an antipsychotic drug whose effect appears to be mediated through antagonist activity ...
Quetiapine is a new-generation antipsychotic medication approved in the treatment of schizophrenia, ...
Recent case reports in medical literatures suggest that more and more second-generation atypical ant...
This paper presents a preliminary examination of the use of quetiapine (an antipsychotic drug) among...
Background: Quetiapine, an atypical antipsychotic endowed with weak dopamine antagonist, potent 5-HT...
ABSTRACT Introduction: Case reports and poison center data have demonstrated that the second-ge...
Background: Quetiapine, an atypical antipsychotic endowed with weak dopamine antagonist, potent 5-HT...
Background: Quetiapine, an atypical antipsychotic endowed with weak dopamine antagonist, potent 5-HT...
Background: Quetiapine, an atypical antipsychotic endowed with weak dopamine antagonist, potent 5-HT...
Recent case reports in medical literatures suggest that more and more second-generation atypical ant...
Quetiapine is one of the atypical antipsychotics that were approved to be used in the treatment of s...
This document is the Accepted Manuscript version. Under embargo until 28 February 2019. Reprinted fr...
Inducing manic or hypomanic symptoms is a well-documented risk during anti- depressive treatment wit...
WOS: 000255873200008PubMed: 18224291Nowadays, there is a widespread use of atypical (second-generati...
Inducing manic or hypomanic symptoms is a well-documented risk during anti- depressive treatment wit...